107 related articles for article (PubMed ID: 21781184)
1. An overview of the molecular pathology of head and neck cancer, and its clinical implications.
Hunter K; Parkinson EK; Thakker N
Periodontol 2000; 2011 Oct; 57(1):132-49. PubMed ID: 21781184
[No Abstract] [Full Text] [Related]
2. [Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas].
Maestro R; Dolcetti R
Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):21-6. PubMed ID: 9036736
[No Abstract] [Full Text] [Related]
3. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in head and neck cancer.
Somers KD; Schechter GL
Otolaryngol Clin North Am; 1992 Oct; 25(5):1065-71. PubMed ID: 1408191
[TBL] [Abstract][Full Text] [Related]
5. Applications of molecular epidemiology to head and neck cancer.
Hart TC
Otolaryngol Clin North Am; 1997 Feb; 30(1):21-34. PubMed ID: 8995134
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss and tumor pathology in head and neck squamous cell carcinoma.
Rybicki BA; Savera AT; Gomez JA; Patel SC; Ballard NE; Benninger MS; Zarbo RJ; Van Dyke DL
Mod Pathol; 2003 Oct; 16(10):970-9. PubMed ID: 14559979
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability in squamous cell carcinoma of the head and neck.
Field JK
Anticancer Res; 1996; 16(4C):2421-31. PubMed ID: 8816845
[TBL] [Abstract][Full Text] [Related]
10. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH
Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559
[TBL] [Abstract][Full Text] [Related]
11. Current role of gene therapy in head and neck cancer.
Ganly I; Soutar DS; Kaye SB
Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
[TBL] [Abstract][Full Text] [Related]
12. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
13. Variability of genetic alterations in different sites of head and neck cancer.
Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
[TBL] [Abstract][Full Text] [Related]
14. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
16. Frequent allelic loss of Dkk-1 locus (10q11.2) is related with low distant metastasis and better prognosis in head and neck squamous cell carcinomas.
Katase N; Gunduz M; Beder LB; Gunduz E; Al Sheikh Ali M; Tamamura R; Yaykasli KO; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2010 Jan; 28(1):103-10. PubMed ID: 19995224
[TBL] [Abstract][Full Text] [Related]
17. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
[TBL] [Abstract][Full Text] [Related]
18. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
19. Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasis.
Gallick GE; Sacks PG; Maxwell SA; Steck PA; Gutterman JU
Prog Clin Biol Res; 1986; 212():97-111. PubMed ID: 3012576
[No Abstract] [Full Text] [Related]
20. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
